| Maari Jenna Bailey, MA CCC-SLP | |
|
1911 116th Ave Ne Ste 100, Bellevue, WA 98004-3046 | |
| (425) 646-5140 | |
| (425) 732-7656 |
| Full Name | Maari Jenna Bailey |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1911 116th Ave Ne Ste 100, Bellevue, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497920359 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | LL00004782 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Maari Jenna Bailey, MA CCC-SLP 1911 116th Ave Ne Ste 100, Bellevue, WA 98004-3046 Ph: (425) 646-5140 | Maari Jenna Bailey, MA CCC-SLP 1911 116th Ave Ne Ste 100, Bellevue, WA 98004-3046 Ph: (425) 646-5140 |
News Archive
FNeoDeck Holdings, Puerto Rico's leading provider of healthcare management solutions, today announced it has partnered with DataMotion, an accredited health information service provider (HISP) supplying email encryption solutions for clinical and non-clinical exchange of protected health information (PHI).
While questions persist about the best ways to detect breast cancer early, a CT imaging system developed at the University of Rochester Medical Center and first unveiled five years ago is in a better position today to enter the fray - at least in a supporting role to conventional mammography.
PENTAX Medical will be exhibiting its very latest endoscopy technologies at one of the world's largest gastrointestinal (GI) congresses, UEG Week 2016 (Booth 7, Hall X5).
A review of the published literature and of internal company documents from the manufacturer of cerivastatin, a cholesterol lowering drug removed from the market in 2001, suggests that information about serious adverse effects of this medication was known to the company within months after this drug was launched
An international team of researchers has identified a new method for selectively killing metastatic melanoma cells, which may lead to new areas for drug development in melanoma - a cancer that is highly resistant to current treatment strategies.
› Verified 5 days ago
Alexandra Marie Gomez, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1417 116th Ave Ne, Suite 110, Bellevue, WA 98004 Phone: 425-688-5900 Fax: 425-688-5912 | |
Elise Morrison, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5150 Village Park Dr Se, Bellevue, WA 98006 Phone: 425-657-0620 Fax: 425-502-8425 | |
Andrea Nicole Jamieson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16120 Ne 8th St, Bellevue, WA 98008 Phone: 425-747-4004 Fax: 425-747-1069 | |
Mrs. Katherine Jeanne Oberhofer, MS CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1417 116th Ave Ne Ste 110, Bellevue, WA 98004 Phone: 425-688-5911 Fax: 425-688-5912 | |
Mrs. Lori Anne Price, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12 Lummi Key, Bellevue, WA 98006 Phone: 425-643-2919 Fax: 425-657-0691 | |
Mackenzie Bush, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13333 Ne Bel Red Rd Ste 100, Bellevue, WA 98005 Phone: 501-352-0101 | |
Genenvieve Decantis, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5150 Village Park Dr Se, Bellevue, WA 98006 Phone: 425-657-0620 |